Search Browse Earnings

Y-mAbs Therapeutics, Inc. — SlamSEC

Y-mAbs Therapeutics, Inc.

Pharmaceutical Preparations·PRINCETON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$84.8M

+30.0% YoY

FY 2024

Adj. EBITDA

-$24.9M

-29.4% margin

FY 2024

Net Income

-$21.4M

-25.3% margin

FY 2024

EPS (Diluted)

-$0.49

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$78.6M

FY 2024

Total Debt

—

Net Cash

$78.6M

FY 2024

Enterprise Value

—

Debt / EBITDA

3.2x

FY 2024

EV / EBITDA

—

Employees

—